GoodRx Holdings Reports Q1 2026 Quarterly Results

What Happened

• GoodRx Holdings, Inc. announced its financial results for the quarter ended March 31, 2026 and furnished a press release with those results in a Form 8-K filed May 6, 2026. The full press release text is included as Exhibit 99.1 to the filing.

Key Details

• Event: Item 2.02 (Results of Operations and Financial Condition) — quarterly results announced.
• Period covered: quarter ended March 31, 2026.
• Filing date and signature: Form 8-K filed May 6, 2026; signed by Christopher McGinnis, Chief Financial Officer & Treasurer.
• Exhibit: Press release dated May 6, 2026 furnished as Exhibit 99.1; cover page XBRL tags embedded in the Inline XBRL document.

Why It Matters

• This 8-K is GoodRx’s official SEC disclosure of its most recent quarterly performance; the attached press release will contain the detailed metrics investors use to evaluate the company (revenue, earnings, guidance, and other operating results).
• Investors should review the attached press release and related financial statements/XBRL data for the specific numbers and any management commentary that could affect near-term valuation or expectations.